The emergence of new respiratory viruses such as swine flu strain (H1N2), avian influenza H5N1 and evolving COVID-19 variants reveal the urgent need for broad-spectrum antivirals. Existing ones like adamantane and nirmatrelvir target specific strains only. To address this, researchers are using artificial intelligence to find similarities between viruses like SARS-CoV-2, influenza and RSV to develop drugs with broad antiviral activity. Wider antiviral treatment could also combat non-respiratory viruses like Ebola and Enterovirus D68.
'A piece of my heart is missing': Son of murdered woman linked to Suffolk Strangler wants answers
Kurtis Pratt has no memories of his mother – he was only four when she disappeared without a trace.
